 | • レポートコード：MRC2-11QY04887 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、133ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は経粘膜ドラッグデリバリーのグローバル市場について調査・分析したレポートです。種類別（パッシブ経皮ドラッグデリバリー、アクティブ経皮ドラッグデリバリー）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別経粘膜ドラッグデリバリーの競争状況、市場シェア ・世界の経粘膜ドラッグデリバリー市場：種類別市場規模 2015年-2020年（パッシブ経皮ドラッグデリバリー、アクティブ経皮ドラッグデリバリー） ・世界の経粘膜ドラッグデリバリー市場：種類別市場規模予測 2021年-2026年（パッシブ経皮ドラッグデリバリー、アクティブ経皮ドラッグデリバリー） ・世界の経粘膜ドラッグデリバリー市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界の経粘膜ドラッグデリバリー市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米の経粘膜ドラッグデリバリー市場分析：米国、カナダ ・ヨーロッパの経粘膜ドラッグデリバリー市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの経粘膜ドラッグデリバリー市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の経粘膜ドラッグデリバリー市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの経粘膜ドラッグデリバリー市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：3M Pharmaceuticals、Acrux Limited、ALZA Corporation、Antares Pharma, Inc.、Apricus BioSciences, Inc、Aveva Drug Delivery Systems、Corium International, Inc、DURECT Corporation、Generex Biotechnology Corporation、Inovio Pharmaceuticals, Inc.、Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)、MedPharm LTD、Mylan, Inc.、Nemaura Pharma Ltd、Nitto Denko Corporation、Noven Pharmaceuticals, Inc.、Pantec Biosolutions AG、Tapemark、tesa Labtec GmbH、TEVA Pharmaceutical Industries Ltd.、Zosano Pharma ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Transmucosal Drug Delivery Market
The global Transmucosal Drug Delivery market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Transmucosal Drug Delivery Scope and Market Size
Transmucosal Drug Delivery market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Transmucosal Drug Delivery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
3M Pharmaceuticals
Acrux Limited
ALZA Corporation
Antares Pharma, Inc.
Apricus BioSciences, Inc
Aveva Drug Delivery Systems
Corium International, Inc
DURECT Corporation
Generex Biotechnology Corporation
Inovio Pharmaceuticals, Inc.
Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
MedPharm LTD
Mylan, Inc.
Nemaura Pharma Ltd
Nitto Denko Corporation
Noven Pharmaceuticals, Inc.
Pantec Biosolutions AG
Tapemark
tesa Labtec GmbH
TEVA Pharmaceutical Industries Ltd.
Zosano Pharma
Market segment by Type, the product can be split into
Passive Transdermal Drug Delivery
Active Transdermal Drug Delivery
Market segment by Application, split into
Hospital
Clinic
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Transmucosal Drug Delivery Revenue
1.4 Market by Type
1.4.1 Global Transmucosal Drug Delivery Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Passive Transdermal Drug Delivery
1.4.3 Active Transdermal Drug Delivery
1.5 Market by Application
1.5.1 Global Transmucosal Drug Delivery Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Transmucosal Drug Delivery Market Perspective (2015-2026)
2.2 Global Transmucosal Drug Delivery Growth Trends by Regions
2.2.1 Transmucosal Drug Delivery Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Transmucosal Drug Delivery Historic Market Share by Regions (2015-2020)
2.2.3 Transmucosal Drug Delivery Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Transmucosal Drug Delivery Market Growth Strategy
2.3.6 Primary Interviews with Key Transmucosal Drug Delivery Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Transmucosal Drug Delivery Players by Market Size
3.1.1 Global Top Transmucosal Drug Delivery Players by Revenue (2015-2020)
3.1.2 Global Transmucosal Drug Delivery Revenue Market Share by Players (2015-2020)
3.1.3 Global Transmucosal Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Transmucosal Drug Delivery Market Concentration Ratio
3.2.1 Global Transmucosal Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Transmucosal Drug Delivery Revenue in 2019
3.3 Transmucosal Drug Delivery Key Players Head office and Area Served
3.4 Key Players Transmucosal Drug Delivery Product Solution and Service
3.5 Date of Enter into Transmucosal Drug Delivery Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Transmucosal Drug Delivery Historic Market Size by Type (2015-2020)
4.2 Global Transmucosal Drug Delivery Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Transmucosal Drug Delivery Market Size by Application (2015-2020)
5.2 Global Transmucosal Drug Delivery Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Transmucosal Drug Delivery Market Size (2015-2020)
6.2 Transmucosal Drug Delivery Key Players in North America (2019-2020)
6.3 North America Transmucosal Drug Delivery Market Size by Type (2015-2020)
6.4 North America Transmucosal Drug Delivery Market Size by Application (2015-2020)
7 Europe
7.1 Europe Transmucosal Drug Delivery Market Size (2015-2020)
7.2 Transmucosal Drug Delivery Key Players in Europe (2019-2020)
7.3 Europe Transmucosal Drug Delivery Market Size by Type (2015-2020)
7.4 Europe Transmucosal Drug Delivery Market Size by Application (2015-2020)
8 China
8.1 China Transmucosal Drug Delivery Market Size (2015-2020)
8.2 Transmucosal Drug Delivery Key Players in China (2019-2020)
8.3 China Transmucosal Drug Delivery Market Size by Type (2015-2020)
8.4 China Transmucosal Drug Delivery Market Size by Application (2015-2020)
9 Japan
9.1 Japan Transmucosal Drug Delivery Market Size (2015-2020)
9.2 Transmucosal Drug Delivery Key Players in Japan (2019-2020)
9.3 Japan Transmucosal Drug Delivery Market Size by Type (2015-2020)
9.4 Japan Transmucosal Drug Delivery Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Transmucosal Drug Delivery Market Size (2015-2020)
10.2 Transmucosal Drug Delivery Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Transmucosal Drug Delivery Market Size by Type (2015-2020)
10.4 Southeast Asia Transmucosal Drug Delivery Market Size by Application (2015-2020)
11 India
11.1 India Transmucosal Drug Delivery Market Size (2015-2020)
11.2 Transmucosal Drug Delivery Key Players in India (2019-2020)
11.3 India Transmucosal Drug Delivery Market Size by Type (2015-2020)
11.4 India Transmucosal Drug Delivery Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Transmucosal Drug Delivery Market Size (2015-2020)
12.2 Transmucosal Drug Delivery Key Players in Central & South America (2019-2020)
12.3 Central & South America Transmucosal Drug Delivery Market Size by Type (2015-2020)
12.4 Central & South America Transmucosal Drug Delivery Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 3M Pharmaceuticals
13.1.1 3M Pharmaceuticals Company Details
13.1.2 3M Pharmaceuticals Business Overview
13.1.3 3M Pharmaceuticals Transmucosal Drug Delivery Introduction
13.1.4 3M Pharmaceuticals Revenue in Transmucosal Drug Delivery Business (2015-2020))
13.1.5 3M Pharmaceuticals Recent Development
13.2 Acrux Limited
13.2.1 Acrux Limited Company Details
13.2.2 Acrux Limited Business Overview
13.2.3 Acrux Limited Transmucosal Drug Delivery Introduction
13.2.4 Acrux Limited Revenue in Transmucosal Drug Delivery Business (2015-2020)
13.2.5 Acrux Limited Recent Development
13.3 ALZA Corporation
13.3.1 ALZA Corporation Company Details
13.3.2 ALZA Corporation Business Overview
13.3.3 ALZA Corporation Transmucosal Drug Delivery Introduction
13.3.4 ALZA Corporation Revenue in Transmucosal Drug Delivery Business (2015-2020)
13.3.5 ALZA Corporation Recent Development
13.4 Antares Pharma, Inc.
13.4.1 Antares Pharma, Inc. Company Details
13.4.2 Antares Pharma, Inc. Business Overview
13.4.3 Antares Pharma, Inc. Transmucosal Drug Delivery Introduction
13.4.4 Antares Pharma, Inc. Revenue in Transmucosal Drug Delivery Business (2015-2020)
13.4.5 Antares Pharma, Inc. Recent Development
13.5 Apricus BioSciences, Inc
13.5.1 Apricus BioSciences, Inc Company Details
13.5.2 Apricus BioSciences, Inc Business Overview
13.5.3 Apricus BioSciences, Inc Transmucosal Drug Delivery Introduction
13.5.4 Apricus BioSciences, Inc Revenue in Transmucosal Drug Delivery Business (2015-2020)
13.5.5 Apricus BioSciences, Inc Recent Development
13.6 Aveva Drug Delivery Systems
13.6.1 Aveva Drug Delivery Systems Company Details
13.6.2 Aveva Drug Delivery Systems Business Overview
13.6.3 Aveva Drug Delivery Systems Transmucosal Drug Delivery Introduction
13.6.4 Aveva Drug Delivery Systems Revenue in Transmucosal Drug Delivery Business (2015-2020)
13.6.5 Aveva Drug Delivery Systems Recent Development
13.7 Corium International, Inc
13.7.1 Corium International, Inc Company Details
13.7.2 Corium International, Inc Business Overview
13.7.3 Corium International, Inc Transmucosal Drug Delivery Introduction
13.7.4 Corium International, Inc Revenue in Transmucosal Drug Delivery Business (2015-2020)
13.7.5 Corium International, Inc Recent Development
13.8 DURECT Corporation
13.8.1 DURECT Corporation Company Details
13.8.2 DURECT Corporation Business Overview
13.8.3 DURECT Corporation Transmucosal Drug Delivery Introduction
13.8.4 DURECT Corporation Revenue in Transmucosal Drug Delivery Business (2015-2020)
13.8.5 DURECT Corporation Recent Development
13.9 Generex Biotechnology Corporation
13.9.1 Generex Biotechnology Corporation Company Details
13.9.2 Generex Biotechnology Corporation Business Overview
13.9.3 Generex Biotechnology Corporation Transmucosal Drug Delivery Introduction
13.9.4 Generex Biotechnology Corporation Revenue in Transmucosal Drug Delivery Business (2015-2020)
13.9.5 Generex Biotechnology Corporation Recent Development
13.10 Inovio Pharmaceuticals, Inc.
13.10.1 Inovio Pharmaceuticals, Inc. Company Details
13.10.2 Inovio Pharmaceuticals, Inc. Business Overview
13.10.3 Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Introduction
13.10.4 Inovio Pharmaceuticals, Inc. Revenue in Transmucosal Drug Delivery Business (2015-2020)
13.10.5 Inovio Pharmaceuticals, Inc. Recent Development
13.11 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
10.11.1 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Company Details
10.11.2 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Business Overview
10.11.3 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Introduction
10.11.4 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Revenue in Transmucosal Drug Delivery Business (2015-2020)
10.11.5 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Recent Development
13.12 MedPharm LTD
10.12.1 MedPharm LTD Company Details
10.12.2 MedPharm LTD Business Overview
10.12.3 MedPharm LTD Transmucosal Drug Delivery Introduction
10.12.4 MedPharm LTD Revenue in Transmucosal Drug Delivery Business (2015-2020)
10.12.5 MedPharm LTD Recent Development
13.13 Mylan, Inc.
10.13.1 Mylan, Inc. Company Details
10.13.2 Mylan, Inc. Business Overview
10.13.3 Mylan, Inc. Transmucosal Drug Delivery Introduction
10.13.4 Mylan, Inc. Revenue in Transmucosal Drug Delivery Business (2015-2020)
10.13.5 Mylan, Inc. Recent Development
13.14 Nemaura Pharma Ltd
10.14.1 Nemaura Pharma Ltd Company Details
10.14.2 Nemaura Pharma Ltd Business Overview
10.14.3 Nemaura Pharma Ltd Transmucosal Drug Delivery Introduction
10.14.4 Nemaura Pharma Ltd Revenue in Transmucosal Drug Delivery Business (2015-2020)
10.14.5 Nemaura Pharma Ltd Recent Development
13.15 Nitto Denko Corporation
10.15.1 Nitto Denko Corporation Company Details
10.15.2 Nitto Denko Corporation Business Overview
10.15.3 Nitto Denko Corporation Transmucosal Drug Delivery Introduction
10.15.4 Nitto Denko Corporation Revenue in Transmucosal Drug Delivery Business (2015-2020)
10.15.5 Nitto Denko Corporation Recent Development
13.16 Noven Pharmaceuticals, Inc.
10.16.1 Noven Pharmaceuticals, Inc. Company Details
10.16.2 Noven Pharmaceuticals, Inc. Business Overview
10.16.3 Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Introduction
10.16.4 Noven Pharmaceuticals, Inc. Revenue in Transmucosal Drug Delivery Business (2015-2020)
10.16.5 Noven Pharmaceuticals, Inc. Recent Development
13.17 Pantec Biosolutions AG
10.17.1 Pantec Biosolutions AG Company Details
10.17.2 Pantec Biosolutions AG Business Overview
10.17.3 Pantec Biosolutions AG Transmucosal Drug Delivery Introduction
10.17.4 Pantec Biosolutions AG Revenue in Transmucosal Drug Delivery Business (2015-2020)
10.17.5 Pantec Biosolutions AG Recent Development
13.18 Tapemark
10.18.1 Tapemark Company Details
10.18.2 Tapemark Business Overview
10.18.3 Tapemark Transmucosal Drug Delivery Introduction
10.18.4 Tapemark Revenue in Transmucosal Drug Delivery Business (2015-2020)
10.18.5 Tapemark Recent Development
13.19 tesa Labtec GmbH
10.19.1 tesa Labtec GmbH Company Details
10.19.2 tesa Labtec GmbH Business Overview
10.19.3 tesa Labtec GmbH Transmucosal Drug Delivery Introduction
10.19.4 tesa Labtec GmbH Revenue in Transmucosal Drug Delivery Business (2015-2020)
10.19.5 tesa Labtec GmbH Recent Development
13.20 TEVA Pharmaceutical Industries Ltd.
10.20.1 TEVA Pharmaceutical Industries Ltd. Company Details
10.20.2 TEVA Pharmaceutical Industries Ltd. Business Overview
10.20.3 TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Introduction
10.20.4 TEVA Pharmaceutical Industries Ltd. Revenue in Transmucosal Drug Delivery Business (2015-2020)
10.20.5 TEVA Pharmaceutical Industries Ltd. Recent Development
13.21 Zosano Pharma
10.21.1 Zosano Pharma Company Details
10.21.2 Zosano Pharma Business Overview
10.21.3 Zosano Pharma Transmucosal Drug Delivery Introduction
10.21.4 Zosano Pharma Revenue in Transmucosal Drug Delivery Business (2015-2020)
10.21.5 Zosano Pharma Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Transmucosal Drug Delivery Key Market Segments
Table 2. Key Players Covered: Ranking by Transmucosal Drug Delivery Revenue
Table 3. Ranking of Global Top Transmucosal Drug Delivery Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Transmucosal Drug Delivery Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Passive Transdermal Drug Delivery
Table 6. Key Players of Active Transdermal Drug Delivery
Table 7. Global Transmucosal Drug Delivery Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Transmucosal Drug Delivery Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Transmucosal Drug Delivery Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Transmucosal Drug Delivery Market Share by Regions (2015-2020)
Table 11. Global Transmucosal Drug Delivery Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Transmucosal Drug Delivery Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Transmucosal Drug Delivery Market Growth Strategy
Table 17. Main Points Interviewed from Key Transmucosal Drug Delivery Players
Table 18. Global Transmucosal Drug Delivery Revenue by Players (2015-2020) (Million US$)
Table 19. Global Transmucosal Drug Delivery Market Share by Players (2015-2020)
Table 20. Global Top Transmucosal Drug Delivery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transmucosal Drug Delivery as of 2019)
Table 21. Global Transmucosal Drug Delivery by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Transmucosal Drug Delivery Product Solution and Service
Table 24. Date of Enter into Transmucosal Drug Delivery Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Transmucosal Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 27. Global Transmucosal Drug Delivery Market Size Share by Type (2015-2020)
Table 28. Global Transmucosal Drug Delivery Revenue Market Share by Type (2021-2026)
Table 29. Global Transmucosal Drug Delivery Market Size Share by Application (2015-2020)
Table 30. Global Transmucosal Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 31. Global Transmucosal Drug Delivery Market Size Share by Application (2021-2026)
Table 32. North America Key Players Transmucosal Drug Delivery Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Transmucosal Drug Delivery Market Share (2019-2020)
Table 34. North America Transmucosal Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 35. North America Transmucosal Drug Delivery Market Share by Type (2015-2020)
Table 36. North America Transmucosal Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 37. North America Transmucosal Drug Delivery Market Share by Application (2015-2020)
Table 38. Europe Key Players Transmucosal Drug Delivery Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Transmucosal Drug Delivery Market Share (2019-2020)
Table 40. Europe Transmucosal Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Transmucosal Drug Delivery Market Share by Type (2015-2020)
Table 42. Europe Transmucosal Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Transmucosal Drug Delivery Market Share by Application (2015-2020)
Table 44. China Key Players Transmucosal Drug Delivery Revenue (2019-2020) (Million US$)
Table 45. China Key Players Transmucosal Drug Delivery Market Share (2019-2020)
Table 46. China Transmucosal Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 47. China Transmucosal Drug Delivery Market Share by Type (2015-2020)
Table 48. China Transmucosal Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 49. China Transmucosal Drug Delivery Market Share by Application (2015-2020)
Table 50. Japan Key Players Transmucosal Drug Delivery Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Transmucosal Drug Delivery Market Share (2019-2020)
Table 52. Japan Transmucosal Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Transmucosal Drug Delivery Market Share by Type (2015-2020)
Table 54. Japan Transmucosal Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Transmucosal Drug Delivery Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Transmucosal Drug Delivery Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Transmucosal Drug Delivery Market Share (2019-2020)
Table 58. Southeast Asia Transmucosal Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Transmucosal Drug Delivery Market Share by Type (2015-2020)
Table 60. Southeast Asia Transmucosal Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Transmucosal Drug Delivery Market Share by Application (2015-2020)
Table 62. India Key Players Transmucosal Drug Delivery Revenue (2019-2020) (Million US$)
Table 63. India Key Players Transmucosal Drug Delivery Market Share (2019-2020)
Table 64. India Transmucosal Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 65. India Transmucosal Drug Delivery Market Share by Type (2015-2020)
Table 66. India Transmucosal Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 67. India Transmucosal Drug Delivery Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Transmucosal Drug Delivery Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Transmucosal Drug Delivery Market Share (2019-2020)
Table 70. Central & South America Transmucosal Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Transmucosal Drug Delivery Market Share by Type (2015-2020)
Table 72. Central & South America Transmucosal Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Transmucosal Drug Delivery Market Share by Application (2015-2020)
Table 74. 3M Pharmaceuticals Company Details
Table 75. 3M Pharmaceuticals Business Overview
Table 76. 3M Pharmaceuticals Product
Table 77. 3M Pharmaceuticals Revenue in Transmucosal Drug Delivery Business (2015-2020) (Million US$)
Table 78. 3M Pharmaceuticals Recent Development
Table 79. Acrux Limited Company Details
Table 80. Acrux Limited Business Overview
Table 81. Acrux Limited Product
Table 82. Acrux Limited Revenue in Transmucosal Drug Delivery Business (2015-2020) (Million US$)
Table 83. Acrux Limited Recent Development
Table 84. ALZA Corporation Company Details
Table 85. ALZA Corporation Business Overview
Table 86. ALZA Corporation Product
Table 87. ALZA Corporation Revenue in Transmucosal Drug Delivery Business (2015-2020) (Million US$)
Table 88. ALZA Corporation Recent Development
Table 89. Antares Pharma, Inc. Company Details
Table 90. Antares Pharma, Inc. Business Overview
Table 91. Antares Pharma, Inc. Product
Table 92. Antares Pharma, Inc. Revenue in Transmucosal Drug Delivery Business (2015-2020) (Million US$)
Table 93. Antares Pharma, Inc. Recent Development
Table 94. Apricus BioSciences, Inc Company Details
Table 95. Apricus BioSciences, Inc Business Overview
Table 96. Apricus BioSciences, Inc Product
Table 97. Apricus BioSciences, Inc Revenue in Transmucosal Drug Delivery Business (2015-2020) (Million US$)
Table 98. Apricus BioSciences, Inc Recent Development
Table 99. Aveva Drug Delivery Systems Company Details
Table 100. Aveva Drug Delivery Systems Business Overview
Table 101. Aveva Drug Delivery Systems Product
Table 102. Aveva Drug Delivery Systems Revenue in Transmucosal Drug Delivery Business (2015-2020) (Million US$)
Table 103. Aveva Drug Delivery Systems Recent Development
Table 104. Corium International, Inc Company Details
Table 105. Corium International, Inc Business Overview
Table 106. Corium International, Inc Product
Table 107. Corium International, Inc Revenue in Transmucosal Drug Delivery Business (2015-2020) (Million US$)
Table 108. Corium International, Inc Recent Development
Table 109. DURECT Corporation Business Overview
Table 110. DURECT Corporation Product
Table 111. DURECT Corporation Company Details
Table 112. DURECT Corporation Revenue in Transmucosal Drug Delivery Business (2015-2020) (Million US$)
Table 113. DURECT Corporation Recent Development
Table 114. Generex Biotechnology Corporation Company Details
Table 115. Generex Biotechnology Corporation Business Overview
Table 116. Generex Biotechnology Corporation Product
Table 117. Generex Biotechnology Corporation Revenue in Transmucosal Drug Delivery Business (2015-2020) (Million US$)
Table 118. Generex Biotechnology Corporation Recent Development
Table 119. Inovio Pharmaceuticals, Inc. Company Details
Table 120. Inovio Pharmaceuticals, Inc. Business Overview
Table 121. Inovio Pharmaceuticals, Inc. Product
Table 122. Inovio Pharmaceuticals, Inc. Revenue in Transmucosal Drug Delivery Business (2015-2020) (Million US$)
Table 123. Inovio Pharmaceuticals, Inc. Recent Development
Table 124. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Company Details
Table 125. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Business Overview
Table 126. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Product
Table 127. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Revenue in Transmucosal Drug Delivery Business (2015-2020) (Million US$)
Table 128. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Recent Development
Table 129. MedPharm LTD Company Details
Table 130. MedPharm LTD Business Overview
Table 131. MedPharm LTD Product
Table 132. MedPharm LTD Revenue in Transmucosal Drug Delivery Business (2015-2020) (Million US$)
Table 133. MedPharm LTD Recent Development
Table 134. Mylan, Inc. Company Details
Table 135. Mylan, Inc. Business Overview
Table 136. Mylan, Inc. Product
Table 137. Mylan, Inc. Revenue in Transmucosal Drug Delivery Business (2015-2020) (Million US$)
Table 138. Mylan, Inc. Recent Development
Table 139. Nemaura Pharma Ltd Company Details
Table 140. Nemaura Pharma Ltd Business Overview
Table 141. Nemaura Pharma Ltd Product
Table 142. Nemaura Pharma Ltd Revenue in Transmucosal Drug Delivery Business (2015-2020) (Million US$)
Table 143. Nemaura Pharma Ltd Recent Development
Table 144. Nitto Denko Corporation Company Details
Table 145. Nitto Denko Corporation Business Overview
Table 146. Nitto Denko Corporation Product
Table 147. Nitto Denko Corporation Revenue in Transmucosal Drug Delivery Business (2015-2020) (Million US$)
Table 148. Nitto Denko Corporation Recent Development
Table 149. Noven Pharmaceuticals, Inc. Company Details
Table 150. Noven Pharmaceuticals, Inc. Business Overview
Table 151. Noven Pharmaceuticals, Inc. Product
Table 152. Noven Pharmaceuticals, Inc. Revenue in Transmucosal Drug Delivery Business (2015-2020) (Million US$)
Table 153. Noven Pharmaceuticals, Inc. Recent Development
Table 154. Pantec Biosolutions AG Company Details
Table 155. Pantec Biosolutions AG Business Overview
Table 156. Pantec Biosolutions AG Product
Table 157. Pantec Biosolutions AG Revenue in Transmucosal Drug Delivery Business (2015-2020) (Million US$)
Table 158. Pantec Biosolutions AG Recent Development
Table 159. Tapemark Company Details
Table 160. Tapemark Business Overview
Table 161. Tapemark Product
Table 162. Tapemark Revenue in Transmucosal Drug Delivery Business (2015-2020) (Million US$)
Table 163. Tapemark Recent Development
Table 164. tesa Labtec GmbH Company Details
Table 165. tesa Labtec GmbH Business Overview
Table 166. tesa Labtec GmbH Product
Table 167. tesa Labtec GmbH Revenue in Transmucosal Drug Delivery Business (2015-2020) (Million US$)
Table 168. tesa Labtec GmbH Recent Development
Table 169. TEVA Pharmaceutical Industries Ltd. Company Details
Table 170. TEVA Pharmaceutical Industries Ltd. Business Overview
Table 171. TEVA Pharmaceutical Industries Ltd. Product
Table 172. TEVA Pharmaceutical Industries Ltd. Revenue in Transmucosal Drug Delivery Business (2015-2020) (Million US$)
Table 173. TEVA Pharmaceutical Industries Ltd. Recent Development
Table 174. Zosano Pharma Company Details
Table 175. Zosano Pharma Business Overview
Table 176. Zosano Pharma Product
Table 177. Zosano Pharma Revenue in Transmucosal Drug Delivery Business (2015-2020) (Million US$)
Table 178. Zosano Pharma Recent Development
Table 179. Research Programs/Design for This Report
Table 180. Key Data Information from Secondary Sources
Table 181. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Transmucosal Drug Delivery Market Share by Type: 2020 VS 2026
Figure 2. Passive Transdermal Drug Delivery Features
Figure 3. Active Transdermal Drug Delivery Features
Figure 4. Global Transmucosal Drug Delivery Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Others Case Studies
Figure 8. Transmucosal Drug Delivery Report Years Considered
Figure 9. Global Transmucosal Drug Delivery Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Transmucosal Drug Delivery Market Share by Regions: 2020 VS 2026
Figure 11. Global Transmucosal Drug Delivery Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Transmucosal Drug Delivery Market Share by Players in 2019
Figure 14. Global Top Transmucosal Drug Delivery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transmucosal Drug Delivery as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Transmucosal Drug Delivery Revenue in 2019
Figure 16. North America Transmucosal Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Transmucosal Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Transmucosal Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Transmucosal Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Transmucosal Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Transmucosal Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Transmucosal Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
経皮ドラッグデリバリーシステムの世界市場（～2026年） Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other type…- ドラッグデリバリー技術の世界市場（～2026年） Market Analysis and Insights: Global Drug Delivery Technologies Market The global Drug Delivery Technologies market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Drug Delivery Technologies Scope and Market Size Drug Deliver…
- 鎮痛剤デリバリーの世界市場（～2026年） Drug delivery refers to approaches, formulations, technologies and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect. Drug delivery is often approached via a drug's chemical formulation, but it may also involve medical devices o…
- 高度ドラッグデリバリーシステムの世界市場（～2026年） Advanced drug delivery systems are the improved methods for delivering the drug molecule to the targeted site in a more controlled manner. These methods are developed in order to improve the efficacy ratio of the currently available drugs. Delivering drug at the controlled rate, slow and targeted de…
- 徐放性ドラッグデリバリーの世界市場（～2026年） Controlled drug delivery is one which delivers the drug at a predetermined rate, for locally or systemically, for a specified period of time. Controlled drug delivery systems can include the maintenance of druglevels within a desired range, the need for fewer administrations, optimal use of the drug…